Antibody Drug Conjugates and Breast Cancer: Insights from a Pharmacy Times Peer Exchange

Pharmacists share key insights about the use of ADCs for treatment of breast cancer.

EP: 1.Pharmacy Focus: Oncology Edition - A Conversation About Biden's Cancer Moonshot Program

EP: 2.Pharmacy Focus: Oncology Edition - PARP Inhibitors in Ovarian Cancer

EP: 3.Pharmacy Focus: Oncology Edition - What You Missed at ASCO 2022

EP: 4.Pharmacy Focus: Oncology Edition - A Look Ahead at the Pipeline for Melanoma

EP: 5.Pharmacy Focus: Oncology Edition - An Update on Prostate Cancer and the Growing Role of Pharmacists

EP: 6.Pharmacy Focus: Oncology Edition - Experts See Promising Future for the Treatment of Acute Lymphoblastic Leukemia

EP: 7.Pharmacy Focus: Oncology Edition - Pharmacists Play Key Role in Non–Small Cell Lung Cancer

EP: 8.Pharmacy Focus: Oncology Edition - Breast Cancer Treatments Are Rapidly Expanding

EP: 9.Pharmacy Focus: Oncology Edition - Consider Treatment Sequences Carefully in Myeloma

EP: 10.Pharmacy Focus: Oncology Edition - A Look Into Psychedelic Medicines for Oncology Care

EP: 11.Pharmacy Focus: Oncology Edition - PARP Inhibitors Are Changing the Game in Prostate Cancer

EP: 12.Pharmacy Focus: Oncology Edition- A Practical, Real-World Understanding of the Enhancing Oncology Model

EP: 13.Pharmacy Focus: Oncology Edition- Latest Updates in Non-Small Cell Lung Cancer Treatment

EP: 14.Pharmacy Focus: Oncology Edition- Integrating Oncology Pharmacists into Multidisciplinary Care Teams for Improved Patient Outcomes

EP: 15.Pharmacy Focus: Oncology Edition- Pharmacists Pivotal Role in Driving Clinical Trial Research

EP: 16.Pharmacy Focus: Oncology Edition- Benefits of Subcutaneous Amivantamab for Lung Cancer Treatment

EP: 17.Pharmacy Focus - Oncology Edition: The Link Between Gut Health and Colon Cancer, Exploring the Wellness Innovation Network

EP: 18.Pharmacy Focus- Oncology Edition: Delayed Breast Cancer Screenings

EP: 19.Pharmacy Focus - Oncology Edition: Advancing Brain Cancer Research and Treatment

EP: 20.Pharmacy Focus: Oncology Edition- Exploring Pelareorep: A Novel Immunotherapy for Advanced Breast Cancer

EP: 21.Pharmacy Focus: Oncology Edition - Discussing Increasing Rates of Lung Cancer in Young Adults and Emerging Precision Treatments

EP: 22.Pharmacy Focus: Oncology Edition – Key Insights and Interviews From the 2024 SABCS Meeting

EP: 23.The AQUILA Debate: Daratumumab for Treatment of Smoldering Multiple Myeloma

EP: 24.From Screening to Survival: The Pharmacist’s Role in Colorectal Cancer

Now Viewing

EP: 25.Antibody Drug Conjugates and Breast Cancer: Insights from a Pharmacy Times Peer Exchange

Related Videos

Related Content

Advertisement

May 5th 2025

GPRC5D-Targeted CAR T-Cell Therapy Shows Promise After BCMA Treatment Failure

Alexandra Gerlach, Associate Editor

April 29th 2025

Insights from a Pharmacy Times Peer Exchange: ADC Drug Design and HER2 Ultra-Low Breast Cancer Indiciations

Alexandra Gerlach, Associate Editor

May 5th 2025

Pharmacist-Led Care in Palliative Settings: Using Anticholinergics Thoughtfully and Compassionately

Diana Violanti, PharmD Pamela S. Moore, PharmD, BCGP Alana Hippensteele, Lead Editor

April 22nd 2025

The RIVAWAR Trial and ACS Guidelines for LV Thrombus

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP Aislinn Antrim, Managing Editor

May 5th 2025

INX-315 Granted FDA Fast Track Designation for Platinum-Resistant or Refractory Ovarian Cancer

Gillian McGovern, Associate Editor

May 3rd 2025

Research Identifies Need for Increased Evidence-Based Use of Buspirone

Aislinn Antrim, Managing Editor

Related Content

Advertisement

May 5th 2025

GPRC5D-Targeted CAR T-Cell Therapy Shows Promise After BCMA Treatment Failure

Alexandra Gerlach, Associate Editor

April 29th 2025

Insights from a Pharmacy Times Peer Exchange: ADC Drug Design and HER2 Ultra-Low Breast Cancer Indiciations

Alexandra Gerlach, Associate Editor

May 5th 2025

Pharmacist-Led Care in Palliative Settings: Using Anticholinergics Thoughtfully and Compassionately

Diana Violanti, PharmD Pamela S. Moore, PharmD, BCGP Alana Hippensteele, Lead Editor

April 22nd 2025

The RIVAWAR Trial and ACS Guidelines for LV Thrombus

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP Aislinn Antrim, Managing Editor

May 5th 2025

INX-315 Granted FDA Fast Track Designation for Platinum-Resistant or Refractory Ovarian Cancer

Gillian McGovern, Associate Editor

May 3rd 2025

Research Identifies Need for Increased Evidence-Based Use of Buspirone

Aislinn Antrim, Managing Editor